METASTRON 37 MBq România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

metastron 37 mbq

ge healthcare limited - marea britanie - stronȚiu cloride - sol. inj. - 37 mbq/ml - trat. paliativ al durerii (preparate pentru sistemul osos) diferite radiofarmaceutice pt.trat. paliativ al durerii

DOTAGRAF 0,5 mmol/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

dotagraf 0,5 mmol/ml

sanochemia pharmazeutika gmbh - austria - acid gadotericum - sol. inj. in flac. multidoza - 0,5mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice

FDG-RMC 185 MBq/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fdg-rmc 185 mbq/ml

ruder medikol ciklotron d.o.o. - croatia - fludeoxiglucoza (18f) - sol. inj. - 185mbq/ml - preparate pentru detectarea tumorilor alte radiofarmaceutice pt. detectarea tumorilor

GADOVIST 1,0 mmol/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gadovist 1,0 mmol/ml

bayer ag - germania - gadobutrolum - sol inj. in seringa preumpluta - 1,0mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice

GADOVIST 1,0 mmol/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gadovist 1,0 mmol/ml

bayer ag - germania - gadobutrolum - sol. inj. - 1,0mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice

MEMOVIST 1 mmol/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

memovist 1 mmol/ml

bayer ag - germania - gadobutrolum - sol. inj. in seringa preumpluta - 1mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice

Byooviz Uniunea Europeană - română - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologice - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ximluci Uniunea Europeană - română - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ranivisio Uniunea Europeană - română - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).